InVivo appoints Dr. Richard Toselli CEO: 5 things to know

Written by Mackenzie Garrity | February 05, 2018 | Print  |

InVivo Therapeutics named Richard Toselli, MD, permanent CEO and president. He had been serving as acting CEO since Dec. 2017.

Here are five things to know:

 

1. In addition to serving as CEO, Dr. Toselli will serve on the company's board of directors.

 

2. Dr. Toselli will continue serving as CMO, a role he has been serving since joining InVivo in July 2017.

 

3. Throughout his career, Dr. Toselli held leadership positions at DePuy Synthes, Johnson & Johnson and Sanofi.

 

4. Dr. Toselli is a board-certified neurosurgeon specializing in spine surgery.

 

5. He previously served as the director of the spine center at Chapel Hill-based University of North Carolina.

 

More articles on devices and implants:
Ceterix Orthopaedics completes enrollment in NovoStitch meniscal repair study: 4 things to know
OrthoXel's Apex Tibial Nailing System receives approval to hit U.S. and European markets: 4 insights
Stryker, Smith & Nephew, Zimmer Biomet & more: 10 device company notes

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months